Advertisements
Feeds:
Posts
Comments

Search Results for 'Ovarian Cancer'


Study Finds that Both Women and their Primary Care Physicians Confusion over Ovarian Cancer Symptoms May Lead to Misdiagnosis Reporter: Stephen J. Williams, Ph.D. This post discusses the recently released “The Every Woman Study” conducted by the World Ovarian Cancer Coalition.  For full PDF of the study please click here: WOCC-Every-Woman-Study-Summary-Report-Oct-16 The findings are summarized nicely […]

Read Full Post »


A Curated History of the Science Behind the Ovarian Cancer β-Blocker Trial Curator: Stephen J. Williams, Ph.D.   This post is a follow-up on the two reports found in this Open Access Journal https://pharmaceuticalintelligence.com/2015/09/16/ovarian-cancer-survival-increased-5-months-overall-with-beta-blockers-study-the-speaker/ AND https://pharmaceuticalintelligence.com/2013/04/08/beta-blockers-help-in-better-survival-in-ovarian-cancer/ in order to explain some of the background which went into the development of these reports. A recent paper […]

Read Full Post »


Model mimicking clinical profile of patients with ovarian cancer @ Yale School of Medicine Reporter: Aviva Lev-Ari, PhD, RN Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence Natalia J. Sumi1, Eydis Lima1, John Pizzonia2, Sean P. Orton3, Vinicius Craveiro1, Wonduk Joo1, Jennie C. Holmberg1, Marta Gurrea1, Yang Yang-Hartwich1, Ayesha Alvero1, Gil […]

Read Full Post »


Overall survival for epithelial ovarian cancer (EOC) patients is prolonged approximately 5 months as a result of treatment with beta blockers, a type … Sourced through Scoop.it from: thespeaker.co See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »


Endometrial Cancer: Mutations, Molecular Types and Immune Responses Evoked by Mutation-prone Endometrial, Ovarian Cancer Subtypes Curator: Aviva Lev-Ari, PhD, RN   This Open Access Online Scientific Journal represents a repository of curated scientific literature on the following types of cancer of relevance to the subject matter of this article. See below the FRONTIER of Research […]

Read Full Post »


Scientists have discovered the signaling pathway whereby a master regulator of cancer cell proteins – known as Src – leads to ovarian cancer progression when exposed to stress hormones. Source: http://www.mdanderson.org See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »


Good and Bad News Reported for Ovarian Cancer Therapy Reporter, Curator: Stephen J. Williams, Ph.D.   In a recent Fierce Biotech report “FDA review red-flags AstraZeneca’s case for ovarian cancer drug olaparib”, John Carroll reports on a disappointing ruling by the FDA on AstraZeneca’s PARP1 inhibitor olaparib for maintenance therapy in women with cisplatin refractory […]

Read Full Post »


Good and Bad News Reported for Ovarian Cancer Therapy Reporter, Curator: Stephen J. Williams, Ph.D.   In a recent Fierce Biotech report “FDA review red-flags AstraZeneca’s case for ovarian cancer drug olaparib”, John Carroll reports on a disappointing ruling by the FDA on AstraZeneca’s PARP inhibitor olaparib for maintenance therapy in women with cisplatin refractory […]

Read Full Post »


Efficacy of Ovariectomy in Presence of BRCA1 vs BRCA2 and the Risk for Ovarian Cancer Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 3/8/2014 Tel Aviv Researchers Find New Way To Fight Ovarian Cancer By NoCamels Team March 03, 2014 0 Comments Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. […]

Read Full Post »


Genetic Testing for Women at Risk of Cancer Reporter: Aviva Lev-Ari PhD, RN Published: May 16, 2013 To the Editor: For Op-Ed, follow@nytopinion and to hear from the editorial page editor, Andrew Rosenthal, follow@andyrNYT. In her thoughtful article about her choice to undergo a double mastectomy, Angelina Jolie said the cost of genetic testing for BRCA1 […]

Read Full Post »

Next »